プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Oliver K.に依頼

Germany

Chemist (PhD) | Process Optimization & Digitalization For Chemistry, Pharma & Biotech)

プロフィール概要

I am a PhD chemist specializing in process optimization, Design of Experiments (DoE), and digitalization for the chemical, pharmaceutical, and biotech industries. With a background in organic synthesis and several years of academic experience, I now focus on helping SMEs move from trial-and-error experimentation to data-driven process development. I design and analyze DoE studies for reaction optimization, scale-up, and robustness evaluation—saving time, reducing costs, and generating documentation that meets GMP and audit requirements. My expertise includes: - **Process Optimization & DoE**: Screening → optimization → robustness (JMP, Minitab, Python) - **Flow & Batch Chemistry**: Feasibility studies, parameter optimization, scale-up risk assessments - **Digitalization & SaaS**: Translating lab workflows into digital tools and lightweight SaaS solutions - **GMP-Aware Documentation**: SOPs, templates, and structured handover packages Deliverables typically include DoE designs, statistical analysis reports, risk assessments, and implementation roadmaps. I can also support technical documentation, literature reviews, and training materials. I work with SMEs seeking pragmatic, results-oriented solutions that accelerate development and improve data quality. I offer both fixed-price packages (e.g., DoE QuickStart) and hourly consulting for longer projects. Let’s discuss how we can make your R&D workflows more efficient, data-driven, and ready for digital transformation.

専門分野

• ☆ Analytical Chemistry
• ☆ Separation & Purification
• ☆ Spectroscopy
• ☆ NMR Spectroscopy
• ☆ Mass Spectrometry
• ☆ Optical Rotation
• ☆ Organic Chemistry
• ☆ Chemical Engineering
• ☆ Process Chemistry
• ☆ Medicinal Chemistry
• ☆ CMC Documentation
• ☆ Technical & Scientific Writing
• ☆ Journal Selection
• ☆ Manuscript & Journal Article Writing
• ☆ SOP & Protocol Writing
• ☆ Literature Review
• ☆ Traditional/Narrative Literature Review

サービス

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Medical Writing, Non-Medical Regulatory Writing, Technical Writing, General Proofreading & Editing

Research Market Research, User Research, Feasibility Study, Technology Scouting, Fact Checking, Gap Analysis, Scientific and Technical Research, Systematic Literature Review

Consulting Digital Strategy Consulting, Operations Consulting, Scientific and Technical Consulting, Regulatory Consulting, Manufacturing Consulting

Data & AI Predictive Modeling, Statistical Analysis, Algorithm Design-Non ML, Algorithm Design-ML, Data Visualization, Data Processing, Data Insights

Product Development Product Evaluation, Product Validation, Manufacturing, Quality Assurance & Control (QA/QC), Product Compliance , Concept Development

職務経験

CEO

CovaSyn GmbH

11月 2024 - 現在

学歴

Dr. rer. nat.

Martin-Luther Universität Halle-Wittenberg - Germany

9月 2012 - 12月 2024

認定資格

• Sachkunde nach Paragraph 5 Abs. 2 Chemikalien-Verbotsverordnung

  Land Sachsen-Anhalt

  9月 2016 - 現在

• Certificate- Good Manafacturing Practice (GMP)

  GMP academy

  9月 2022 - 9月 2022

出版物

JOURNAL ARTICLE

Toni C. Denner, Niels Heise, Julian Zacharias, Oliver Kraft, Sophie Hoenke, René Csuk (2023). Small Structural Differences Govern the Carbonic Anhydrase II Inhibition Activity of Cytotoxic Triterpene Acetazolamide Conjugates . Molecules.

Toni Denner, Niels Heise, Julian Zacharias, Oliver Kraft, Sophie Hoenke, René Csuk (2023). Small Structural Differences Govern the Carbonic Anhydrase II Inhibition Activity of Cytotoxic Triterpene Acetazolamide Conjugates . Molecules.

Oliver Kraft, Sophie Hoenke, René Csuk (2022). A tormentic acid-homopiperazine-rhodamine B conjugate of single-digit nanomolar cytotoxicity and high selectivity for several human tumor cell lines . European Journal of Medicinal Chemistry Reports.

Oliver Kraft, Ann-Kathrin Hartmann, Sophie Hoenke, Immo Serbian, René Csuk(2022). Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents . International Journal of Molecular Sciences. 23. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 4362. {MDPI} {AG}

Oliver Kraft, Ann-Kathrin Hartmann, Sophie Hoenke, Immo Serbian, René Csuk (2022). Madecassic Acid—A New Scaffold for Highly Cytotoxic Agents . International Journal of Molecular Sciences.

Oliver Kraft, Marie Kozubek, Sophie Hoenke, Immo Serbian, Daniel Major, René Csuk(2021). Cytotoxic triterpenoid–safirinium conjugates target the endoplasmic reticulum . European Journal of Medicinal Chemistry. 209. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 112920. Elsevier {BV}